No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪111.30 M‬EUR
‪−4.44 M‬EUR
‪15.10 M‬EUR
‪13.70 M‬
Beta (1Y)


Juho-Pekka Himberg
Employees (FY)
Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. It operates through the Devices and Software segments. The Devices segment develops, commercializes and manufactures handheld fundus cameras that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, gakucoma and Age Related Mascular Degeneration. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company was founded by Seppo Henrik Kopsala on December 20, 2004 and is headquartered in Oulu, Finland.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OPTOMED is 6.33 EUR — it has decreased by 6.77% in the past 24 hours. Watch OPTOMED PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange OPTOMED PLC stocks are traded under the ticker OPTOMED.
OPTOMED stock has risen by 11.84% compared to the previous week, the month change is a 51.25% rise, over the last year OPTOMED PLC has showed a 84.55% increase.
We've gathered analysts' opinions on OPTOMED PLC future price: according to them, OPTOMED price has a max estimate of 7.50 EUR and a min estimate of 5.80 EUR. Watch OPTOMED chart and read a more detailed OPTOMED PLC stock forecast: see what analysts think of OPTOMED PLC and suggest that you do with its stocks.
OPTOMED reached its all-time high on Jul 15, 2021 with the price of 19.15 EUR, and its all-time low was 2.02 EUR and was reached on Oct 26, 2022. View more price dynamics on OPTOMED chart.
See other stocks reaching their highest and lowest prices.
OPTOMED stock is 10.88% volatile and has beta coefficient of 1.53. Track OPTOMED PLC stock price on the chart and check out the list of the most volatile stocks — is OPTOMED PLC there?
Today OPTOMED PLC has the market capitalization of ‪120.70 M‬, it has increased by 12.39% over the last week.
Yes, you can track OPTOMED PLC financials in yearly and quarterly reports right on TradingView.
OPTOMED PLC is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
OPTOMED net income for the last quarter is ‪−1.09 M‬ EUR, while the quarter before that showed ‪−1.53 M‬ EUR of net income which accounts for 28.76% change. Track more OPTOMED PLC financial stats to get the full picture.
No, OPTOMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 114.00 employees. See our rating of the largest employees — is OPTOMED PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTOMED PLC EBITDA is ‪−1.94 M‬ EUR, and current EBITDA margin is −18.21%. See more stats in OPTOMED PLC financial statements.
Like other stocks, OPTOMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTOMED PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTOMED PLC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTOMED PLC stock shows the strong buy signal. See more of OPTOMED PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.